Article ID Journal Published Year Pages File Type
5509619 Clinica Chimica Acta 2017 6 Pages PDF
Abstract
Our data suggest that CD16− M/L could serve as promising biomarkers for distinguishing active disease from quiescent disease in both UC and CD. In addition, they could be used as supplements to other disease activity indicators, such as hsCRP and ESR.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , , , , , , ,